Popular Articles
Burdock Root

Lutonix, Inc. Announces First Patient Enrollments In Three Separate Clinical Trials
Lutonix, Inc., a privately held medical device start-up, announced that patient enrollment is underway for its three simultaneous first-in-human clinical trials. The three studies are designed to test whether the proprietary Lutonix Drug Coated Balloon (DCB) Catheter is safe and effective in the treatment of vascular narrowing.
generic viagra online
MorphoSys Reports Filing For Phase 1b/2a Trial For Its Lead Program MOR103 In Rheumatoid Arthritis
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that the Company has submitted an application for the authorization of a phase 1b/2a clinical study in patients with active rheumatoid arthritis (RA) for its lead drug MOR103, a fully human HuCAL-derived monoclonal antibody directed against Granulocyte Macrophage-Colony Stimulating Factor. The trial, which will be conducted in multiple centers in several European countries, is expected to enroll 135 patients in total beginning in the second half of 2009. Additionally, the Company today reported positive results from the phase 1 clinical study for MOR103 in healthy volunteers. The results of this study indicate that MOR103 is generally safe and well tolerated at all doses administered.
News of the day
'Green' Fireworks May Brighten Eco-Friendly 4th Of July Displays In Future
With millions of people in the United States eagerly awaiting those July 4 fireworks displays - and our Canadian neighbors doing likewise for their July 1 Canada Day celebrations - here"s a prospect for those light shows of the future likely to ignite a smile on Mother Nature"s face: A new generation of "green" fireworks is quietly making its way toward the sky.
Oncology

Politicians Must Face Reality Of Tough NHS Financial Future, Says The King's Fund

Commenting in response to today"s report from the NHS Confederation on the financial prospects for the NHS, The King"s Fund"s Chief Executive Niall Dickson said: "After a decade of unprecedented spending, the NHS could face drastic cuts after 2011. This report backs up our analysis, which shows that the prospects for the NHS after 2011 will be severe unless the service responds now by improving efficiency and reforming the way care is delivered. "Our analysis shows the NHS will probably have to operate under these much harsher financial conditions up to 2017 - yet at the same time more older people, more technology and higher expectations will create more demand for health care. We do have a window of opportunity - just under two years - when budgets still look relatively generous and the service can prepare for the lean years ahead. "In practical terms that means every NHS organisation should be embarking on a rigorous programme of cost control, and every organisation should be working with others to redesign services to improve quality and save money. The two are not necessarily incompatible. "But what is also required is political courage. We do not need politicians boasting that they will "spend more than the other lot" when they all know perfectly well that no matter who is in power the next few years will be about managing with less. This is not the time for reassurance - it is a time for difficult messages and support for doctors, nurses and managers who are prepared to reshape services at local level. "That will mean driving efficiency throughout the system while focusing on the quality of care; concentrating some specialist services in fewer hospitals; moving other services into the community and learning to manage patients better to avoid unnecessary admissions and unnecessarily long stays in hospital. The alternative is to shy away from this agenda, pretend it will all be fine, and risk throwing away the significant advances that have been made in recent years." The King"s Fund is a charity that seeks to understand how the health system in England can be improved. Using that insight, we help to shape policy, transform services and bring about behaviour change. Our work includes research, analysis, leadership development and service improvement. We also offer a wide range of res to help everyone working in health to share knowledge, learning and ideas. The King"s Fund


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):